Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

Journal of Inorganic Biochemistry

Volumn 105, Issue 11, 2011, Pages 1489-1499

  Tomljenovic, Lucija ^a   Shaw, Christopher A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adjuvants; Aluminum; Autism; Autoimmunity; Brain inflammation; Vaccines

Indexed keywords

ALUMINUM VACCINE; ANTHRAX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; PEDVAX; PNEUMOCOCCUS VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANTHRAX; ARTHRITIS; ARTICLE; AUTISM; AUTOIMMUNE THYROIDITIS; BODY WEIGHT; CHILD; CHRONIC FATIGUE SYNDROME; CROHN DISEASE; DIPHTHERIA; ENTERITIS; HAEMOPHILUS; HAEMOPHILUS INFECTION; HEPATITIS A; HEPATITIS B; HUMAN; INFECTION PREVENTION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGIC MYOFASCIITIS; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTIPLE SCLEROSIS; MUSCLE DISEASE; PERSIAN GULF SYNDROME; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; TETANUS; UNITED STATES;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; AUSTRALIA; CANADA; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FINLAND; GREAT BRITAIN; HUMANS; ICELAND; INFANT; INFANT, NEWBORN; PHOSPHATES; PREVALENCE; SWEDEN; UNITED STATES;

EID: 81855192715     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2011.08.008     Document Type: Article

References (189)

1. M.V. Johnston Brain & Development 17 1995 301 306
2. J.G. Dorea, and R.C. Marques Journal of Exposure Science & Environmental Epidemiology 20 2010 598 601
3. S. Avishai-Eliner, K.L. Brunson, C.A. Sandman, and T.Z. Baram Trends in Neurosciences 25 2002 518 524
4. Agency for toxic substances, disease registry (ATSDR) Toxicological profile for aluminum. Atlanta, GA 2008 http://www.atsdr.cdc.gov/toxprofiles/ tp22.html
5. W. Zheng Journal of Toxicology. Clinical Toxicology 39 2001 711 719
6. L. Hewitson, B.J. Lopresti, C. Stott, N.S. Mason, and J. Tomko Acta Neurobiologiae Experimentalis 70 2010 147 164 (Wars)
7. L. Hewitson, L.A. Houser, C. Stott, G. Sackett, J.L. Tomko, D. Atwood, L. Blue, and E.R. White Journal of Toxicology and Environmental Health. Part A 73 2010 1298 1313
8. M.A. Galic, S.J. Spencer, A. Mouihate, and Q.J. Pittman Integrative and Comparative Biology 49 2009 237 245
9. M.A. Galic, K. Riazi, J.G. Heida, A. Mouihate, N.M. Fournier, S.J. Spencer, L.E. Kalynchuk, G.C. Teskey, and Q.J. Pittman The Journal of Neuroscience 28 2008 6904 6913
10. N.R. Rose Lupus 19 2010 354 358
11. K. Tsumiyama, Y. Miyazaki, and S. Shiozawa PloS One 4 2009 e8382
12. Centers for Disease Control and Prevention (CDC) Child & Adolescent Immunization Schedules for persons aged 0-6 years, 7-18 years, and "catch-up schedule" and Past Childhood Immunization Schedules 2010 http://www.cdc.gov/vaccines/recs/schedules/child-schedule.htm#chgs
13. A surveillance community Network for Vaccine Preventable Infectious Diseases (EUVAC.NET) The United Kingdom Childhood Vaccination Schedule, as on 19th April 20 http://www.euvac.net/graphics/euvac/vaccination/unitedkingdom.html
14. L. Tomljenovic, and C.A. Shaw Current Medicinal Chemistry 18 2011 2630 2637
15. Food, Drug Administration (FDA) Workshop on Non-clinical Safety Evaluation of Preventative Vaccines: Recent Advances and Regulatory Considerations (2002) http://www.fda.gov/downloads/biologicsbloodvaccines/ newsevents/workshopsmeetingsconferences/transcriptsminutes/ucm054459.pdf
16. L. Tomljenovic Journal of Alzheimer's Disease 23 2011 567 598
17. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Annals of Neurology 57 2005 67 81
18. R.J. Kelleher III, and M.F. Bear Cell 135 2008 401 406
19. I. Rapin, and R. Katzman Annals of Neurology 43 1998 7 14
20. C.A. Pardo, D.L. Vargas, and A.W. Zimmerman International Review of Psychiatry 17 2005 485 495
21. K.S. Reddy BMC Medical Genetics 6 2005 3
22. P. Ashwood, A. Enstrom, P. Krakowiak, I. Hertz-Picciotto, R.L. Hansen, L.A. Croen, S. Ozonoff, I.N. Pessah, and J. Van de Water Journal of Neuroimmunology 204 2008 149 153
23. R.L. Blaylock, and A. Strunecka Current Medicinal Chemistry 16 2009 157 170
24. H.H. Cohly, and A. Panja International Review of Neurobiology 71 2005 317 341
25. P.A. Garay, and A.K. McAllister Front Synaptic Neuroscience 2 2010 136
26. V.K. Singh, R.P. Warren, J.D. Odell, W.L. Warren, and P. Cole Brain, Behavior, and Immunity 7 1993 97 103
27. J.R. Walton Neurotoxicology 30 2009 182 193
28. N.J. Bishop, R. Morley, J.P. Day, and A. Lucas The New England Journal of Medicine 336 1997 1557 1561
29. C.A. Shaw, and M.S. Petrik Journal of Inorganic Biochemistry 103 2009 1555 1562
30. A. Batista-Duharte, E.B. Lindblad, and E. Oviedo-Orta Toxicology Letters 203 2011 97 105
31. E. Israeli, N. Agmon-Levin, M. Blank, and Y. Shoenfeld Lupus 18 2009 1217 1225
32. Y. Shoenfeld, and N. Agmon-Levin Journal of Autoimmunity 36 2011 4 8
33. S.C. Eisenbarth, O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell Nature 453 2008 1122 1126
34. C. Exley, P. Siesjo, and H. Eriksson Trends in Immunology 31 2010 103 109
35. T.C. Eickhoff, and M. Myers Vaccine 20 Suppl. 3 2002 S1 S4
36. E. Miller, N. Andrews, P. Waight, H. Findlow, L. Ashton, A. England, E. Stanford, M. Matheson, J. Southern, E. Sheasby, D. Goldblatt, and R. Borrow Clinical and Vaccine Immunology 18 2011 367 372
37. T. Verstraeten, D. Descamps, M.P. David, T. Zahaf, K. Hardt, P. Izurieta, G. Dubin, and T. Breuer Vaccine 26 2008 6630 6638
38. S.M. Garland, M. Hernandez-Avila, C.M. Wheeler, G. Perez, D.M. Harper, S. Leodolter, G.W. Tang, D.G. Ferris, M. Steben, J. Bryan, F.J. Taddeo, R. Railkar, M.T. Esser, H.L. Sings, M. Nelson, J. Boslego, C. Sattler, E. Barr, and L.A. Koutsky The New England Journal of Medicine 356 2007 1928 1943
39. P.A. Offit, and R.K. Jew Pediatrics 112 2003 1394 1397
40. A. Seubert, E. Monaci, M. Pizza, D.T. O'Hagan, and A. Wack Journal of Immunology 180 2008 5402 5412
41. A.B. Hill Proceedings of the Royal Society of Medicine 58 1965 295 300
42. U.S. Department of Education 24th Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act, Appendix A, Data Tables, Table 1-9, Age Group 6-21 http://www2.ed.gov/about/reports/annual/ osep/2002/index.html
43. U.S. Department of Education 26th Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act, Table 1-9, Age Group 6-21 http://www2.ed.gov/about/reports/annual/osep/2004/index.html
44. U.S. Department of Education 28th Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act, Table 1-9, Age Groups 3-5 and 6-21 http://www2.ed.gov/about/reports/annual/osep/2006/parts- b-c/index.html
45. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count (2005), Table 1-3, Students ages 6 through 21 served under IDEA, Part B, by disability category and state https://www.ideadata.org/arc-toc7.asp#partbCC
46. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count Table 1-7, Children and Students Served under IDEA, Part B, in the U.S. and Outlying Areas, by Age and Disability Category 2005 https://www.ideadata. org/arc-toc7.asp#partbCC
47. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count Table 1-3, Students Ages 6 through 21 Served under IDEA, Part B, by Disability Category and State 2006 https://www.ideadata.org/arc-toc8.asp#partbCC
48. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count Table 1-7, Children and Students Served under IDEA, Part B, in the U.S. and Outlying Areas, by Age and Disability Category 2006 https://www.ideadata. org/arc-toc8.asp#partbCC
49. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count 2007 Table 1-3, Students ages 6 through 21 served under IDEA, Part B, by disability category and state https://www.ideadata.org/arc-toc9.asp#partbCC
50. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count 2007 Table 1-7, Children and students served under IDEA, Part B, in the U.S. and outlying areas, by age and disability category https://www.ideadata. org/arc-toc9.asp#partbCC
51. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count Table 1-3, Students ages 6 through 21 served under IDEA, Part B, by disability category and state 2008 https://www.ideadata.org/arc-toc10. asp#partbCC
52. The Individuals with Disabilities Education Act (IDEA) Data Accountability Center Data Tables for OSEP State Reported Data, Part B Child Count Table 1-7, Children and Students Served under IDEA, Part B, in the U.S. and Outlying Areas, by Age and Disability Category 2008 https://www.ideadata. org/arc-toc10.asp#partbCC
53. R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus, J.F. Pellissier, P. Chariot, and F.J. Authier Brain 124 2001 1821 1831
54. Public Health Agency of Canada Immunization Schedules for Infants and Children, source: Canadian Immunization Guide Seventh Edition 2006 http://www.phac-aspc.gc.ca/im/is-cv/
55. Australian Government Department of Health and Aging National Immunisation Program (NIP) Schedule last modified 28th April 2010 http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips2
56. Swedish Institute for Infectious Disease Control (SMITTSKYDDSINSTITUTET) Barnvaccinationer ges enligt nedanstaende tabell http://www. smittskyddsinstitutet.se/upload/amnesomraden/vaccin/vaccinationsschema.pdf
57. KTL National Public Health Institute Finish National Vaccination Programme April 17th 2008 http://www.ktl.fi/attachments/suomi/osastot/roko/roto/ finnish-vaccination-programme.pdf
58. A surveillance community Network for Vaccine Preventable Infectious Diseases (EUVAC.NET) The Icelandic childhood vaccination schedule as on October 19th 2007 http://www.euvac.net/graphics/euvac/vaccination/iceland.html
59. Wyeth Canada Meningitec product monograph Date of last approval 2007 http://www.wyeth.ca/en/products/Product%20Monographs%20PDFs/Meningitec-PM.pdf
60. Bioport Corp. Anthrax Vaccine Adsorbed (Biothrax™) Revised January 31 2002 http://www.fda.gov/OHRMS/DOCKETS/98fr/05n-0040-bkg0001.pdf
61. Merck&Co Inc. Recombivax HB product monograph Approved March 23 2009 http://www.merck.ca/assets/en/pdf/products/RECOMBIVAX-HB-09-03-a-126922-E.pdf
62. GlaxoSmithKline Hiberix product information Date of last amendment 9 April 2009 http://www.gsk.com.au/resources.ashx/vaccineproductschilddataproinfo/ 232/FileName/D8AE2CF1E6ED5097F04CDB946BC28E69/PI-Hiberix.pdf
63. Centre for Infectious Diseases and Microbiology What's new in pneumococcal disease-surveillance using conventional and molecular methods http://www.cidmpublichealth.org/resources/pdf/bsp/bsp13-june-09.pdf
64. Australian Advisory Board on Autism Spectrum Disorders The prevalence of autism in Australia. Can it be established from existing data? Overview and Report 2006 http://autismaus.com.au/uploads/pdfs/PrevalenceReport.pdf
65. A. Morrow, P. De Wals, G. Petit, M. Guay, and L.J. Erickson The Canadian Journal of Infection Diseases Medical Microbiology 18 2007 121 127
66. P. De Wals The Pediatric Infectious Disease Journal 23 2004 S280 S284
67. E. Fombonne, R. Zakarian, A. Bennett, L. Meng, and D. McLean-Heywood Pediatrics 118 2006 e139 e150
68. A surveillance community Network for Vaccine Preventable Infectious Diseases (EUVAC.NET) The Swedish Childhood Vaccination Schedule as of 20th April 2010 http://www.euvac.net/graphics/euvac/vaccination/sweden.html
69. C. Gillberg, M. Cederlund, K. Lamberg, and L. Zeijlon Journal of Autism and Developmental Disorders 36 2006 429 435
70. A surveillance community Network for Vaccine Preventable Infectious Diseases (EUVAC.NET) The Finnish Childhood Vaccination Schedule as on 6 January 2011 http://www.euvac.net/graphics/euvac/vaccination/finland.html
71. M. Kielinen, S.L. Linna, and I. Moilanen European Child & Adolescent Psychiatry 9 2000 162 167
72. P. Magnusson, and E. Saemundsen Journal of Autism and Developmental Disorders 31 2001 153 163
73. M.D. Kogan, S.J. Blumberg, L.A. Schieve, C.A. Boyle, J.M. Perrin, R.M. Ghandour, G.K. Singh, B.B. Strickland, E. Trevathan, and P.C. van Dyck Pediatrics 124 2009 1395 1403
74. S. Baron-Cohen, F.J. Scott, C. Allison, J. Williams, P. Bolton, F.E. Matthews, and C. Brayne The British Journal of Psychiatry 194 2009 500 509
75. U.K. Department of Health Immunisation against infectious disease - "The Green Book"(2007), Part 1 Principles, practices and procedures, Chapter 11: Immunisation schedule http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-079917
76. Swedish Institute for Infectious Disease Control (SMITTSKYDDSINSTITUTET) The present and previous Swedish general vaccination program http://www.smittskyddsinstitutet.se/in-english/activities/the-swedish- vaccination-program/the-present-and-previous-swedish-general-vaccination- program/
77. S. Iwarson Vaccine 16 Suppl. 1998 S63 S64
78. P.H. Westfall, and S.S. Young Resampling-Based Multiple Testing 1993 John Wiley & Sons, Inc. New York
79. S. Haddad, C. Restieri, and K. Krishnan Journal of Toxicology and Environmental Health. Part A 64 2001 453 464
80. R. van Reekum, D.L. Streiner, and D.K. Conn The Journal of Neuropsychiatry and Clinical Neurosciences 13 2001 318 325
81. J. Rhawn Neuropsychiatry, Neuropsychology, and Clinical Neuroscience third ed 1996 Lippincott Williams & Wilkins http://brainmind.com/ EmotionalBrainDevelopment4.html
82. M.R. Gunnar, L. Brodersen, K. Krueger, and J. Rigatuso Child Development 67 1996 877 889
83. R.J. Ellingson, and J.F. Peters Electroencephalography and Clinical Neurophysiology 49 1980 112 124
84. H.O. Besedovsky, and A. Rey Handbook of Neurochemistry and Molecular Neurobiology A. Lajtha, H.O. Besedovsky, A. Galoyan, 2008 Springer 495
85. S.W. Porges The Neurobiology of Autism M.L. Bauman, T.L. Kemper, 2005 The Johns Hopkins University Press Baltimore, Maryland 65 78
86. M.A. Polimeni, A.L. Richdale, and A.J. Francis Journal of Intellectual Disability Research 49 2005 260 268
87. R. Tuchman, and I. Rapin Lancet Neurology 1 2002 352 358
88. K. Ballaban-Gil, and R. Tuchman Mental Retardation and Developmental Disabilities Research Reviews 6 2000 300 308
89. N.W. Baylor, W. Egan, and P. Richman Vaccine 20 Suppl. 3 2002 S18 S23
90. Food and Drug Administration (FDA) Department of Health and Human Services Aluminum in large and small volume parenterals used in total parenteral nutrition amendment June 2003 http://edocket.access.gpo.gov/cfr-2005/aprqtr/ pdf/21cfr201.323.pdf
91. M. Wang, J.T. Chen, D.Y. Ruan, and Y.Z. Xu Neuroscience 113 2002 411 419
92. M.M. Lopes, and L.Q.A. Caldas Toxicology Letters 205S 2011 S60 S179
93. Sanofi Pasteur MSD Limited Revaxis, summary of Product Characteristics last updated May 2008 http://www.medicines.org.uk/emc/document.aspx?documentid= 15259
94. M. Couette, M.F. Boisse, P. Maison, P. Brugieres, P. Cesaro, X. Chevalier, R.K. Gherardi, A.C. Bachoud-Levi, and F.J. Authier Journal of Inorganic Biochemistry 103 2009 1571 1578
95. C. Exley, L. Swarbrick, R.K. Gherardi, and F.J. Authier Medical Hypotheses 72 2009 135 139
96. F.J. Authier, P. Cherin, A. Creange, B. Bonnotte, X. Ferrer, A. Abdelmoumni, D. Ranoux, J. Pelletier, D. Figarella-Branger, B. Granel, T. Maisonobe, M. Coquet, J.D. Degos, and R.K. Gherardi Brain 124 2001 974 983
97. M.S. Petrik, M.C. Wong, R.C. Tabata, R.F. Garry, and C.A. Shaw Neuromolecular Medicine 9 2007 83 100
98. K. Redhead, G.J. Quinlan, R.G. Das, and J.M. Gutteridge Pharmacology & Toxicology 70 1992 278 280
99. S. Iwarson Vaccine 11 Suppl. 1 1993 S18 S20
100. S.A. Cowan Eurosurveillance 10 2005 http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=2827
101. C.M. Gallagher, and M.S. Goodman Toxicological and Environmental Chemistry 90 2008 997 1008
102. C.M. Gallagher, and M.S. Goodman Journal of Toxicology and Environmental Health. Part A 73 2010 1665 1677
103. B.E. Eldred, A.J. Dean, T.M. McGuire, and A.L. Nash The Medical Journal of Australia 184 2006 170 175
104. R.A. Yokel, C.L. Hicks, and R.L. Florence Food and Chemical Toxicology 46 2008 2261 2266
105. R.A. Yokel, and P.J. McNamara Pharmacology & Toxicology 88 2001 159 167
106. GlaxoSmithKline Boostrix product monograph, combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination date of approval October 21 2009 http://www.gsk.ca/english/docs-pdf/Boostrix-PM-20091021-EN.pdf
107. P.E. Makidon, A.U. Bielinska, S.S. Nigavekar, K.W. Janczak, J. Knowlton, A.J. Scott, N. Mank, Z. Cao, S. Rathinavelu, M.R. Beer, J.E. Wilkinson, L.P. Blanco, J.J. Landers, and J.R. Baker Jr. PloS One 3 2008 e2954
108. C. Exley, and Aluminium and Medicine Molecular and Supramolecular Bioinorganic Chemistry: Applications in Medical Sciences A.L.R. Merce, J. Felcman, M.A.L. Recio, 2008 Nova Science Publishers, Inc. New York 45 68
109. P.M. Egan, M.T. Belfast, J.A. Gimenez, R.D. Sitrin, and R.J. Mancinelli Vaccine 27 2009 3175 3180
110. S.L. Hem Vaccine 20 Suppl. 3 2002 S40 S43
111. P. Ashwood, S. Wills, and J. Van de Water Journal of Leukocyte Biology 80 2006 1 15
112. B. Havik, S. Le Hellard, M. Rietschel, H. Lybaek, S. Djurovic, M. Mattheisen, T.W. Muhleisen, F. Degenhardt, L. Priebe, W. Maier, R. Breuer, T.G. Schulze, I. Agartz, I. Melle, T. Hansen, C.R. Bramham, M.M. Nothen, B. Stevens, T. Werge, O.A. Andreassen, S. Cichon, and V.M. Steen Biological Psychiatry 70 2011 35 42
113. P. Ashwood, and J. Van de Water Clinical & Developmental Immunology 11 2004 165 174
114. K.M. Lucin, and T. Wyss-Coray Neuron 64 2009 110 122
115. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Biological Psychiatry 63 2008 801 808
116. A.D. Cohen, and Y. Shoenfeld Journal of Autoimmunity 9 1996 699 703
117. S.D. Bilbo, J.C. Biedenkapp, A. Der-Avakian, L.R. Watkins, J.W. Rudy, and S.F. Maier The Journal of Neuroscience 25 2005 8000 8009
118. G.W. Konat, B.E. Lally, A.A. Toth, and A.K. Salm Metabolic Brain Disease 2011 10.1007/s11011-011-9244-z
119. B. Stevens, N.J. Allen, L.E. Vazquez, G.R. Howell, K.S. Christopherson, N. Nouri, K.D. Micheva, A.K. Mehalow, A.D. Huberman, B. Stafford, A. Sher, A.M. Litke, J.D. Lambris, S.J. Smith, S.W. John, and B.A. Barres Cell 131 2007 1164 1178
120. L.M. Boulanger Neuron Glia Biology 1 2004 283 289
121. C.J. Shatz Neuron 64 2009 40 45
122. C.A. Goddard, D.A. Butts, and C.J. Shatz Proceedings of the National Academy of Sciences of the United States of America 104 2007 6828 6833
123. G.S. Huh, L.M. Boulanger, H. Du, P.A. Riquelme, T.M. Brotz, and C.J. Shatz Science 290 2000 2155 2159
124. R.A. Corriveau, G.S. Huh, and C.J. Shatz Neuron 21 1998 505 520
125. D.P. Schafer, and B. Stevens Biochemical Society Transactions 38 2010 476 481
126. L.M. Boulanger Neuron 64 2009 93 109
127. L. Fourgeaud, and L.M. Boulanger The European Journal of Neuroscience 32 2010 207 217
128. H.O. Besedovsky, and A. del Rey Neurochemical Research 36 2010 1 6
129. I.J. Elenkov, R.L. Wilder, G.P. Chrousos, and E.S. Vizi Pharmacological Reviews 52 2000 595 638
130. F. Eskandari, J.I. Webster, and E.M. Sternberg Arthritis Research & Therapy 5 2003 251 265
131. S. Rivest Progress in Brain Research 181 2010 43 53
132. N.P. Turrin, and S. Rivest (Maywood) Experimental Biology and Medicine 229 2004 996 1006
133. A. del Rey, E. Roggero, A. Randolf, C. Mahuad, S. McCann, V. Rettori, and H.O. Besedovsky Proceedings of the National Academy of Sciences of the United States of America 103 2006 16039 16044
134. A. del Rey, C. Wolff, J. Wildmann, A. Randolf, A. Hahnel, H.O. Besedovsky, and R.H. Straub Arthritis and Rheumatism 58 2008 3090 3099
135. R.L. Wilder Annual Review of Immunology 13 1995 307 338
136. C.A. Siegrist, and R. Aspinall Nature Reviews. Immunology 9 2009 185 194
137. C.A. Siegrist Vaccine 19 2001 3331 3346
138. S.B. Dillon, S.G. Demuth, M.A. Schneider, C.B. Weston, C.S. Jones, J.F. Young, M. Scott, P.K. Bhatnaghar, S. LoCastro, and N. Hanna Vaccine 10 1992 309 318
139. X. Li, H. Zheng, Z. Zhang, M. Li, Z. Huang, H.J. Schluesener, Y. Li, and S. Xu Nanomedicine: Nanotechnology, Biology and Medicine 5 2009 473 479
140. S. Laye, P. Parnet, E. Goujon, and R. Dantzer Brain Research. Molecular Brain Research 27 1994 157 162
141. B. Havik, H. Rokke, G. Dagyte, A.K. Stavrum, C.R. Bramham, and V.M. Steen Neuroscience 148 2007 925 936
142. C. Eroglu, and B.A. Barres Nature 468 2010 223 231
143. M.K. Belmonte, G. Allen, A. Beckel-Mitchener, L.M. Boulanger, R.A. Carper, and S.J. Webb The Journal of Neuroscience 24 2004 9228 9231
144. B. Zikopoulos, and H. Barbas The Journal of Neuroscience 30 2010 14595 14609
145. B. Platt, D.O. Carpenter, D. Busselberg, K.G. Reymann, and G. Riedel Experimental Neurology 134 1995 73 86
146. M. Wang, J.T. Chen, D.Y. Ruan, and Y.Z. Xu Brain Research 899 2001 193 200
147. A. Vojdani, A.W. Campbell, E. Anyanwu, A. Kashanian, K. Bock, and E. Vojdani Journal of Neuroimmunology 129 2002 168 177
148. W.A. Banks, and A.J. Kastin Neuroscience and Biobehavioral Reviews 13 1989 47 53
149. R.A. Yokel Journal of Alzheimer's Disease 10 2006 223 253
150. G.J. Fournie, M. Mas, B. Cautain, M. Savignac, J.F. Subra, L. Pelletier, A. Saoudi, D. Lagrange, M. Calise, and P. Druet Journal of Autoimmunity 16 2001 319 326
151. B. Zinka, E. Rauch, A. Buettner, F. Rueff, and R. Penning Vaccine 24 2006 5779 5780
152. S.D. Bilbo, L.H. Levkoff, J.H. Mahoney, L.R. Watkins, J.W. Rudy, and S.F. Maier Behavioral Neuroscience 119 2005 93 301
153. S.D. Bilbo, N.J. Newsum, D.B. Sprunger, L.R. Watkins, J.W. Rudy, and S.F. Maier Brain, Behavior, and Immunity 21 2007 332 342
154. H. Hagberg, and C. Mallard Current Opinion in Neurology 18 2005 117 123
155. A. Lerner Annals of the New York Academy of Sciences 1107 2007 329 345
156. I.J. Elenkov, and G.P. Chrousos Trends in Endocrinology and Metabolism 10 1999 359 368
157. R.K. Gherardi Revista de Neurologia 159 2003 162 164 (Paris)
158. A. Skowera, A. Cleare, D. Blair, L. Bevis, S.C. Wessely, and M. Peakman Clinical and Experimental Immunology 135 2004 294 302
159. G. Broderick, A. Kreitz, J. Fuite, M.A. Fletcher, S.D. Vernon, and N. Klimas Brain, Behavior, and Immunity 25 2010 302 313
160. S. Gupta, S. Aggarwal, B. Rashanravan, and T. Lee Journal of Neuroimmunology 85 1998 106 109
161. P. Ashwood, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, I.N. Pessah, and J. Van de Water Brain, Behavior, and Immunity 25 2011 840 849
162. V.K. Singh Journal of Neuroimmunology 66 1996 143 145
163. C.A. Molloy, A.L. Morrow, J. Meinzen-Derr, K. Schleifer, K. Dienger, P. Manning-Courtney, M. Altaye, and M. Wills-Karp Journal of Neuroimmunology 172 2006 198 205
164. S. Jha, S.Y. Srivastava, W.J. Brickey, H. Iocca, A. Toews, J.P. Morrison, V.S. Chen, D. Gris, G.K. Matsushima, and J.P. Ting The Journal of Neuroscience 30 2010 15811 15820
165. D. Gris, Z. Ye, H.A. Iocca, H. Wen, R.R. Craven, P. Gris, M. Huang, M. Schneider, S.D. Miller, and J.P. Ting Journal of Immunology 185 2010 974 981
166. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Nature Immunology 12 2011 408 415
167. C. Bauer, P. Duewell, C. Mayer, H.A. Lehr, K.A. Fitzgerald, M. Dauer, J. Tschopp, S. Endres, E. Latz, and M. Schnurr Gut 59 2010 1192 1199
168. M. Aringer, and J.S. Smolen Lupus 13 2004 344 347
169. A. Sabry, H. Sheashaa, A. El-Husseini, K. Mahmoud, K.F. Eldahshan, S.K. George, E. Abdel-Khalek, E.M. El-Shafey, and H. Abo-Zenah Cytokine 35 2006 148 153
170. J.M. Brewer Immunology Letters 102 2006 10 15
171. H. HogenEsch Vaccine 20 Suppl. 3 2002 S34 S39
172. H. Li, S. Nookala, and F. Re Journal of Immunology 178 2007 5271 5276
173. K.M. Smith, P. Garside, R.C. McNeil, and J.M. Brewer Vaccine 24 2006 3035 3043
174. H.L. Davis, R. Weeratna, T.J. Waldschmidt, L. Tygrett, J. Schorr, and A.M. Krieg Journal of Immunology 160 1998 870 876
175. C.L. Brazolot Millan, R. Weeratna, A.M. Krieg, C.A. Siegrist, and H.L. Davis Proceedings of the National Academy of Sciences of the United States of America 95 1998 15553 15558
176. I. Sutton, R. Lahoria, I.L. Tan, P. Clouston, and M.H. Barnett Multiple Sclerosis 15 2009 116 119
177. J.B. Classen The New Zealand Medical Journal 109 1996 195
178. GlaxoSmithKline Engerix-B product monograph July 2010 http://us.gsk.com/products/assets/us-engerixb.pdf
179. G. Delong Journal of Toxicology and Environmental Health. Part A 74 2011 903 916
180. C.J. Newschaffer, M.D. Falb, and J.G. Gurney Pediatrics 115 2005 e277 e282
181. J.G. Gurney, M.S. Fritz, K.K. Ness, P. Sievers, C.J. Newschaffer, and E.G. Shapiro Archives of Pediatrics & Adolescent Medicine 157 2003 622 627
182. H. Yazbak Journal of American Physical Surgery 8 2003 103 107
183. J.R. Walton Neurotoxicology 30 2009 1059 1069
184. N.C. Bowdler, D.S. Beasley, E.C. Fritze, A.M. Goulette, J.D. Hatton, J. Hession, D.L. Ostman, D.J. Rugg, and C.J. Schmittdiel Pharmacology Biochemistry and Behavior 10 1979 505 512
185. J.A. Flendrig, H. Kruis, and H.A. Das Proceedings of the European Dialysis and Transplant Association 13 1976 355 368
186. S.V. Verstraeten, M.S. Golub, C.L. Keen, and P.I. Oteiza Archives of Biochemistry and Biophysics 344 1997 289 294
187. L. Shi, S.H. Fatemi, R.W. Sidwell, and P.H. Patterson The Journal of Neuroscience 23 2003 297 302
188. L. Shi, S.E. Smith, N. Malkova, D. Tse, Y. Su, and P.H. Patterson Brain, Behavior, and Immunity 23 2009 116 123
189. S.H. Fatemi, T.J. Reutiman, T.D. Folsom, H. Huang, K. Oishi, S. Mori, D.F. Smee, D.A. Pearce, C. Winter, R. Sohr, and G. Juckel Schizophrenia Research 99 2008 56 70